Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Guenthner E et al. Copper salts for growth stimulation and alleviation of aortic rupture losses in turkeys. 1978 Poult. Sci. pmid:724600
Kahn SG and Actor P Enhancement of sulfaquinoxaline activity by nystatin. 1966 Poult. Sci. pmid:5962189
Baum GL Antifungal therapy, 1978. 1979 Postgrad Med J pmid:392475
McRipley RJ et al. Evaluation of vaginal antifungal formulations in vivo. 1979 Postgrad Med J pmid:392480
Haller I Modern aspects of testing azole antifungals. 1979 Postgrad Med J pmid:392484
Holbrook WP and Kippax R Sensitivity of Candida albicans from patients with chronic oral candidiasis. 1979 Postgrad Med J pmid:392486
Grigoriu D et al. Aspergillus sinusitis. 1979 Postgrad Med J pmid:523351
Darisipudi MN et al. Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome. 2011 PLoS ONE pmid:21625424
Schulzke JD et al. Anti-diarrheal mechanism of the traditional remedy Uzara via reduction of active chloride secretion. 2011 PLoS ONE pmid:21479205
Kalema N et al. Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. 2012 PLoS ONE pmid:22808020
Caliceti C et al. Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. 2012 PLoS ONE pmid:22859971
Siljamäki E et al. Cholesterol dependence of collagen and echovirus 1 trafficking along the novel α2β1 integrin internalization pathway. 2013 PLoS ONE pmid:23393580
Zemljič Jokhadar Š et al. Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell. 2016 PLoS ONE pmid:27788169
Salyer AC et al. Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. 2016 PLoS ONE pmid:26919709
Kim HJ et al. Post-PKS tailoring steps of a disaccharide-containing polyene NPP in Pseudonocardia autotrophica. 2015 PLoS ONE pmid:25849545
Ono J et al. Widespread Genetic Incompatibilities between First-Step Mutations during Parallel Adaptation of Saccharomyces cerevisiae to a Common Environment. 2017 PLoS Biol. pmid:28114370
Boyce ST and Holder IA Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. 1993 Plast. Reconstr. Surg. pmid:8341750
Margineanu C et al. [The anticandida action of the saponine from Primula (author's transl)]. 1976 Planta Med. pmid:785496
Gubler F et al. Gibberellin signaling in barley aleurone cells. Control of SLN1 and GAMYB expression. 2002 Plant Physiol. pmid:12011350
Sertié JA et al. Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. 2005 Phytomedicine pmid:15957367
Rosato A et al. In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. 2009 Phytomedicine pmid:19616925
Ahua KM et al. Antileishmanial and antifungal acridone derivatives from the roots of Thamnosma rhodesica. 2004 Phytochemistry pmid:15081302
Valitova JN et al. Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. 2011 Phytochemistry pmid:21726881
Joseph-Horne T et al. Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin. 1996 Phytochemistry pmid:8768319
Dos Santos AG et al. The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition. 2017 Phys Chem Chem Phys pmid:29098221
Arrigoni-Martelli E et al. The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema. 1971 Pharmacology pmid:5088647
Wasan KM et al. A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine. 1999 Pharm. Res. pmid:9950297
Mohammadi G et al. Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles. 2017 Pharm. Res. pmid:27928646
Vermerie N et al. Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. 1997 Pharm World Sci pmid:9297733
Sakeer K et al. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. 2010 Jul-Aug Pharm Dev Technol pmid:19772376
Silva FC et al. Nystatin and lidocaine pastilles for the local treatment of oral mucositis. 2017 Pharm Dev Technol pmid:27499389
Pinto Reis C et al. Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. 2016 Pharm Dev Technol pmid:25567611
Wu J and Partridge LD Dissociated dopaminergic neurons from substantia nigra zona compacta in young rats lack functional NMDA receptors. 1998 Pflugers Arch. pmid:9479023
Thodis E et al. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. 1998 Nov-Dec Perit Dial Int pmid:9932656
Williams PF et al. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. 2000 May-Jun Perit Dial Int pmid:10898060
Lye WC Nystatin prophylaxis for fungal peritonitis: to be or not to be? 2007 Sep-Oct Perit Dial Int pmid:17704437
Wong PN et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. 2007 Sep-Oct Perit Dial Int pmid:17704443
Robitaille P et al. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. 1995 Perit Dial Int pmid:7734569
Lo WK and Cheng IK Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD? 1999 Mar-Apr Perit Dial Int pmid:10357198
JAHN CL and CHERRY JD CONGENITAL CUTANEOUS CANDIDIASIS. 1964 Pediatrics pmid:14129091
Klein KC and Blackwood RA Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. 2006 Pediatrics pmid:16816005
Davis TC Chronic vulvovaginitis in children due to Shigella flexneri. 1975 Pediatrics pmid:1098002
Faix RG et al. Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. 1989 Pediatrics pmid:2909957
Cohen-Abbo A Newborn with vesicular rash. Tinea corporis (tinea faciei). 2000 Pediatr. Infect. Dis. J. pmid:10917228
Goins RA et al. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. 2002 Pediatr. Infect. Dis. J. pmid:12506950
Hoppe JE Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group. 1997 Pediatr. Infect. Dis. J. pmid:9076817
Spencer R et al. Antimicrobial therapy for surgical diseases of the gastrointestinal tract. 1968 Pediatr. Clin. North Am. pmid:5638370
Hildick-Smith G Antifungal antibiotics. 1968 Pediatr. Clin. North Am. pmid:4866900
Leibovitz E Strategies for the prevention of neonatal candidiasis. 2012 Pediatr Neonatol pmid:22503254
Hachiya KA et al. Candida esophagitis following antibiotic usage. 1982 May-Jun Pediatr Infect Dis pmid:7145730
Jolivot PA et al. [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. 2012 Pathol. Biol. pmid:22361161
Marcotty T et al. In vitro titration of Theileria parva tick derived stabilates. 2004 Parasitology pmid:15030000
Anwar A et al. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole. 2018 Parasitol. Res. pmid:29218442
Yao JY et al. Evaluation of nystatin isolated from Streptomyces griseus SDX-4 against the ciliate, Ichthyophthirius multifiliis. 2015 Parasitol. Res. pmid:25645004
Rizk NN et al. Use of topical lidocaine, diphenhydramine hydrochloride, nystatin, and gabapentin swish in treatment for post-radiation neuropathy and oral mucositis. 2014 May-Jun Pain Physician pmid:24850125
Kurnatowski P and Kurnatowska AK [Treatment of fungal infections of upper respiratory tract and ear]. 2007 Otolaryngol Pol pmid:17847781
Daniel SJ et al. Is ototopical nystatin ototoxic? A chinchilla model. 2011 Otolaryngol Head Neck Surg pmid:21860059
Neely JG and Nelson RA Orally ingested nystatin powder in water for the stabilization of hearing in patients with fluctuating hearing loss. 1994 Otolaryngol Head Neck Surg pmid:8028914
Milánkovits M [Vaginal infections associated with bacterial vaginosis and periodontal disease--effective diagnostic and therapeutic possibilities]. 2008 Orv Hetil pmid:18977743
Paquet V and Carreira EM Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine. 2006 Org. Lett. pmid:16623556
Willis AM et al. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. 2001 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:11250629
Negm MM Intracanal use of a corticosteroid-antibiotic compound for the management of posttreatment endodontic pain. 2001 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:11598580
Patton LL et al. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. 2001 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:11505264
Redding S et al. Inhibition of Candida albicans biofilm formation on denture material. 2009 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:19426921
Gonzalez-Moles MA et al. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. 2003 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:12789149
Epstein JB et al. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. 2003 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:12931087
Catalán A et al. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18280967
Hamers AD et al. Use of a microtiter plate assay to detect the rate of killing of adherent Candida albicans by antifungal agents. 1996 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:8850482
Ates M et al. The effect of calcium chelating or binding agents on Candida albicans. 2005 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:16243251
Silva MM et al. Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22986242
Kaomongkolgit R et al. Antifungal activity of coronarin D against Candida albicans. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22727093
Ellepola AN et al. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. 1999 Oral Microbiol. Immunol. pmid:10895691
Kuriyama T et al. In vitro susceptibility of oral Candida to seven antifungal agents. 2005 Oral Microbiol. Immunol. pmid:16238594
Chami N et al. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. 2005 Oral Microbiol. Immunol. pmid:15720571
Oji C and Chukwuneke F Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. 2008 Oral Maxillofac Surg pmid:18618163
MaciÄ…g J et al. The Effect of Treatment of Denture-related Stomatitis on Peripheral T Cells and Monocytes. Oral Health Prev Dent pmid:28674706
Chukwuneke F et al. Concurrent Presentation of Burning Mouth Syndrome and Globus Pharyngis in Enugu, Nigeria: A Ten-year Clinical Evaluation. 2014 Oral Health Prev Dent pmid:24624402
Ellepola AN and Samaranayake LP The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. 1998 Oral Dis pmid:10200705
Anil S and Samaranayake LP Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole. 2002 Oral Dis pmid:12206401
Matsubara VH et al. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). 2012 Oral Dis pmid:22059932
Pemberton MN Nystatin and miconazole: pharmacological and clinical evidence regarding interactions with warfarin. 2016 Oral Dis pmid:27416928
Bueno MG et al. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm. 2015 Oral Dis pmid:24219354
Delmas D et al. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. 2004 Oncogene pmid:15480430
Davis JE et al. Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis. 1974 Obstet Gynecol pmid:4604245
Wallenburg HC and Wladimiroff JW Recurrence of vulvovaginal candidosis during pregnancy. Comparison of miconazole vs nystatin treatment. 1976 Obstet Gynecol pmid:787858
DAFTARY SN et al. Vulvovaginal moniliasis (candidiasis) in pregnancy. 1963 Obstet Gynecol pmid:14024592
Brenner RW and Gehring SW Pelvic actinomycosis in the presence of an endocervical contraceptive device. Report of a case. 1967 Obstet Gynecol pmid:6017947
Davis BA Vaginal moniliasis in private practice. 1969 Obstet Gynecol pmid:5791314
McNellis D et al. Treatment of vulvovaginal candidiasis in pregnancy. A comparative study. 1977 Obstet Gynecol pmid:927757
THOMAS HH Candidal vulvovaginitis; treatment with mycostatin. 1957 Obstet Gynecol pmid:13400428
BENCHAKAN V et al. Nystatin vaginal tablets in the treatment of candidal vulvovaginitis. 1956 Obstet Gynecol pmid:13359010
Snow M Giving thrush a thrashing. 2006 Nursing pmid:17079896
Crook WG Solution may be diet and antifungal therapy. 1987 Nurse Pract pmid:3684020
Nystatin. 2006 Mar 28-Apr 3 Nurs Times pmid:16605149
Plevani P et al. In vivo and in vitro effects of rifampicin and streptolydigin on transcription of Kluyveromyces lactis in the presence of nystatin. 1975 Nucleic Acids Res. pmid:1091916
Badaracco G et al. Synthesis of DNA in permeabilized cells of Kluyveromyces lactis. 1978 Nucleic Acids Res. pmid:673862
Akaike N [Patch-clamp method using nystatin]. 1993 Nippon Yakurigaku Zasshi pmid:8330799
Yang Y et al. A chloroplast envelope membrane protein containing a putative LrgB domain related to the control of bacterial death and lysis is required for chloroplast development in Arabidopsis thaliana. 2012 New Phytol. pmid:21916894
Signoretto C et al. Support for the role of Candida spp. in extensive caries lesions of children. 2009 New Microbiol. pmid:19382675
Chang CW et al. Potentiation of inhibitory amino acid receptors-mediated responses by lanthanum in rat sacral dorsal commissural neurons. 2006 Nov-Dec Neurotoxicol Teratol pmid:17045457